Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Boehringer Ingelheim's TNF-alpha-1a launched in Europe for soft tissue sarcoma

Sep. 16, 1999

M-Vax nearing commercialization in several markets

Sep. 16, 1999

Genzyme Molecular Oncology announces initiation of breast cancer vaccine trial

Sep. 16, 1999

Transgene commences phase I trial for treatment of cervical cancer

Sep. 14, 1999

Maxamine treatment leads to tumor regression in preclinical model of prostate cancer

Sep. 14, 1999

LifeTime and Arkios enter oncology alliance

Sep. 13, 1999

Biomira revises collaboration with Chiron for Theratope vaccine

Sep. 7, 1999

Beta LT demonstrates positive results in initial human trials

Sep. 7, 1999

First patient enrolled in York Medical's cancer vaccine trial

Sep. 6, 1999

Immunomedics awarded four grants from the NIH for development of cancer therapies

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...